Altered T cell receptor ligands trigger a subset of early T cell signals
- PMID: 8769476
- DOI: 10.1016/s1074-7613(00)80489-6
Altered T cell receptor ligands trigger a subset of early T cell signals
Abstract
TCR ligands are complexes of peptides and MHC proteins on the surfaces of APCs. Some of these ligands cause T cell proliferation (agonists), while others block it (antagonists). We compared the acid release, calcium flux, and proliferation response of helper T cells to a variety of ligands. We found that all agonist ligands but not most antagonist ligands trigger acid release, a general indicator of early cellular activation. Only a subset of ligands triggering acid release cause sustained calcium flux, and only a subset of these ligands cause T cell proliferation. Antagonist ligands and anti-CD4 antibodies both effectively block T cell proliferation. However, significantly greater antagonist ligand or antibody concentrations are required to block acid release and initial calcium influx. These data demonstrate a hierarchy of early T cell signaling steps and show that altered TCR ligands can initiate some steps while blocking the completion of others.
Similar articles
-
TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type.J Immunol. 2000 Sep 15;165(6):3015-22. doi: 10.4049/jimmunol.165.6.3015. J Immunol. 2000. PMID: 10975810
-
Cutting edge: dueling TCRs: peptide antagonism of CD4+ T cells with dual antigen specificities.J Immunol. 1999 Aug 15;163(4):1750-4. J Immunol. 1999. PMID: 10438905
-
Kinetics and extent of T cell activation as measured with the calcium signal.J Exp Med. 1997 May 19;185(10):1815-25. doi: 10.1084/jem.185.10.1815. J Exp Med. 1997. PMID: 9151707 Free PMC article.
-
Modification of human T-cell responses by altered peptide ligands: a new approach to antigen-specific modification.Intern Med. 1998 Oct;37(10):804-17. doi: 10.2169/internalmedicine.37.804. Intern Med. 1998. PMID: 9840700 Review.
-
Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation.Semin Immunol. 1996 Apr;8(2):83-101. doi: 10.1006/smim.1996.0011. Semin Immunol. 1996. PMID: 8920243 Review.
Cited by
-
A novel combination approach to effectively reduce inflammation and neurodegeneration in multiple sclerosis models.Neurochem Int. 2024 May;175:105697. doi: 10.1016/j.neuint.2024.105697. Epub 2024 Feb 15. Neurochem Int. 2024. PMID: 38364938
-
Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.Rev Neurosci. 2008;19(4-5):327-39. doi: 10.1515/revneuro.2008.19.4-5.327. Rev Neurosci. 2008. PMID: 19145988 Free PMC article. Review.
-
Single-cell NAD(H) levels predict clonal lymphocyte expansion dynamics.Sci Immunol. 2024 Mar 15;9(93):eadj7238. doi: 10.1126/sciimmunol.adj7238. Epub 2024 Mar 15. Sci Immunol. 2024. PMID: 38489349 Free PMC article.
-
Allelic variation of MHC structure alters peptide ligands to induce atypical partial agonistic CD8+ T cell function.J Exp Med. 2003 Jul 7;198(1):99-109. doi: 10.1084/jem.20021796. J Exp Med. 2003. PMID: 12847139 Free PMC article.
-
Early T cell signalling is reversibly altered in PD-1+ T lymphocytes infiltrating human tumors.PLoS One. 2011 Mar 7;6(3):e17621. doi: 10.1371/journal.pone.0017621. PLoS One. 2011. PMID: 21408177 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
